Try our Advanced Search for more refined results
Cannabis
Cannabis Law360 provides breaking news and analysis of emerging and evolving legal issues surrounding cannabis. Coverage ranges from regulatory and policy concerns facing the industry to the business of lawyers who counsel cannabis companies. Among the practice areas covered are intellectual property, mergers & acquisitions and employment.
Sign up for a 7-day FREE trial today!
Latest News in Cannabis
-
January 17, 2025
Philip Morris' ZYN Nicotine Pouches Are 1st To Get FDA's OK
Tobacco giant Philip Morris is the first to secure permission from the U.S. Food and Drug Administration to sell nicotine pouches, with the agency allowing several flavored variants of the company's popular ZYN brand to hit the market after finding that the products could "benefit" smokers looking to quit cigarettes.
-
January 17, 2025
DEA Judge Kicks Pot Rescheduling Back To Administrator
The Drug Enforcement Administration judge who paused hearings on a proposal to loosen federal restrictions on marijuana has kicked the matter back to the agency's administrator after reformers said the DEA stacked the deck against changing pot's status.
-
January 17, 2025
Pot Labs Say Mass. Co. Sold Dud Test Devices In $286M Suit
The owners of more than two dozen cannabis testing labs across the United States and Canada have accused PerkinElmer Health Services Inc. of knowingly selling them equipment that it knew was incapable of handling the sort of tests the labs performed.
-
January 17, 2025
LPL Fined $18M Over Lax Anti-Money Laundering Compliance
The U.S. Securities and Exchange Commission on Friday fined LPL Financial LLC $18 million to settle claims that the firm's anti-money laundering program suffered from significant shortcomings, including the failure to close high-risk accounts such as cannabis-related and international accounts.
-
January 17, 2025
Lowenstein Sandler Can Pursue Trimmed Dispensary Fee Suit
A New Jersey state court judge dismissed part of Lowenstein Sandler LLP's $800,000 fee suit against a cannabis dispensary former client Thursday and told the firm it must give the former client the notice of its right to resolve the fee dispute through arbitration.
Areas of Coverage
- AGENCIES
- U.S. Food & Drug Administration
- Federal Trade Commission
- Drug Enforcement Agency
- U.S. Department of the Treasury
- California Bureau of Cannabis Control
- Department of Health & Human Services
- Financial Crimes Enforcement Network
- U.S. Securities and Exchange Commission
- U.S. Commodity Futures Trading Commission
- U.S. Department of Justice
- State and international regulators
- POLICY & REGULATION
- SAFE Banking Act
- STATES Act
- Marijuana Opportunity Reinvestment and Expungement, or MORE, Act
- Section 280E of the Internal Revenue Code
- Rohrabacher–Farr amendment
- Bank Secrecy Act
- Federal and state legislation
- ENFORCEMENT
- FDA and FTC actions over cannabis’s purported health claims
- IRS actions against cannabis companies
- Antitrust investigations
- Financial regulatory actions
- Federal criminal matters
- State enforcement actions
- LITIGATION
- Civil RICO actions brought against cannabis concerns
- Employment disputes
- Securities class actions
- Intellectual property matters
- Consumer class actions
- Bankruptcy
- Tax disputes
- Challenges to federal or state regulations
- TRANSACTIONS
- M&A activity involving cannabis companies
- Commercial real estate transactions
- PROFILES
- Personnel moves
- Profiles of law firm cannabis practices
- Federal and state policymakers and lawmakers
- General counsel interviews
READERSHIP
- Cannabis lawyers at large to medium-sized law firms and boutiques
- In-house counsel, compliance officers and executives at cannabis companies
- Counsel and executives at venture capital and investment firms
- Policymakers at federal and state agencies
- Federal and state lawmakers
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.